MANGROVE PARTNERS IM, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001535392

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q1 2025 · 155 positions · Total reported value $909.39M · Top-10 concentration 43.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 143 new · 48 cut · 205 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, MANGROVE PARTNERS IM, LLC disclosed 155 equity positions with a combined reported value of $909.39M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.9% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q1 2025 were RIO ($60.00M), LBRDK ($47.57M), LLYVK ($43.35M). By sector, the heaviest allocations are Consumer Discretionary 24.0%, Financials 16.2%. Versus the prior quarter, allocation shifted toward Other (+4.7pp), Materials (+4.7pp) and away from Consumer Discretionary (-1.9pp), Health Care (-4.9pp).

Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 31% of names.

The largest new positions opened in Q1 2025 were MRP ($31.59M), ECVT ($28.14M), NWSA ($14.40M).

Of the 205 positions fully exited versus the prior quarter, the largest were TSEM ($27.37M), SSNC ($26.74M), BRSL ($24.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • MRP MILLROSE PPTYS INC · $31.59M
  • ECVT ECOVYST INC · $28.14M
  • NWSA NEWS CORP NEW · $14.40M
  • INDV INDIVIOR PHARMACEUTICALS INC · $6.79M
  • FTW PRESIDIO PRODTN CO · $4.55M
  • DYNC DYNAMIX CORP · $4.48M
  • HVII HENNESSY CAPITAL INVESTMENT · $4.45M
  • QSEAU QUARTZSEA ACQUISITION CORP · $4.12M

Fully Exited (vs previous quarter)

  • TSEM TOWER SEMICONDUCTOR LTD · prev qtr: $27.37M
  • SSNC SS&C TECH HLDGS · prev qtr: $26.74M
  • BRSL BRIGHTSTAR LOTTERY PLC · prev qtr: $24.65M
  • KROS KEROS THERAPEUTICS INC · prev qtr: $11.66M
  • RFACW RF ACQUISITION CORP · prev qtr: $10.90M
  • GLSTW GLOBAL STAR ACQUISITION INC · prev qtr: $10.76M
  • TETWF WTS/TECHNOLOGY & TELECOM ACQ CORP EXP02/15/2027 · prev qtr: $5.95M
  • FFC FLAHERTY & CRUMRIN PFD & INM · prev qtr: $4.07M

Insider Transactions (Form 4)

Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-78070 (status: Approved), registered 2013-05-20
  • Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: mangrovepartners.com

Portfolio Structure

  • 426 positions · $1.52B reported value (Q2 2026)
  • Top 10 holdings = 38.1% of reported value
  • Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
  • Average position size: $3.57M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 18.5%
  • Information Technology 13.9%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
  • 127 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 16.2%
Health Care 11.6%
Materials 7.4%
Technology 3.8%
Other 25.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 998.66K $60.00M 6.60%
6.60%
Add
2 559.34K $47.57M 5.23%
5.23%
Add
3 636.12K $43.35M 4.77%
4.77%
Hold
4 1.10M $40.39M 4.44%
4.44%
Hold
5 415.16K $40.09M 4.41%
4.41%
Hold
6 1.93M $39.49M 4.34%
4.34%
Hold
7 340.90K $34.83M 3.83%
3.83%
Hold
8 1.08M $32.67M 3.59%
3.59%
Add
9 1.19M $31.59M 3.47%
3.47%
New
10 1.93M $29.70M 3.27%
3.27%
Hold
11 2.17M $28.33M 3.12%
3.12%
Hold
12 4.54M $28.14M 3.09%
3.09%
New
13 463.88K $27.78M 3.05%
3.05%
Add
14 947.05K $23.99M 2.64%
2.64%
Add
15 223.30K $23.35M 2.57%
2.57%
Hold
16 8.64M $19.43M 2.14%
2.14%
Hold
17 395.38K $19.12M 2.10%
2.10%
Hold
18 2.82M $18.93M 2.08%
2.08%
Hold
19 527.64K $16.16M 1.78%
1.78%
Hold
20 493.06K $16.14M 1.77%
1.77%
Hold
21 338.64K $15.56M 1.71%
1.71%
Hold
22 394.84K $15.50M 1.71%
1.71%
Add
23 1.06M $15.36M 1.69%
1.69%
Hold
24 529.20K $14.40M 1.58%
1.58%
New
25 793.19K $9.83M 1.08%
1.08%
Hold
26 681.03K $8.91M 0.98%
0.98%
Hold
27 84.94K $8.29M 0.91%
0.91%
Reduce
28 4.60M $8.10M 0.89%
0.89%
Hold
29 1.23M $7.87M 0.87%
0.87%
Hold
30 650.00K $7.81M 0.86%
0.86%
Hold
31 625.00K $7.48M 0.82%
0.82%
Hold
32 607.68K $7.46M 0.82%
0.82%
Hold
33 712.80K $6.79M 0.75%
0.75%
New
34 619.00K $6.78M 0.74%
0.74%
Add
35 500.03K $6.73M 0.74%
0.74%
Hold
36 525.09K $5.99M 0.66%
0.66%
Hold
37 99.26K $5.90M 0.65%
0.65%
Hold
38 95.00K $4.80M 0.53%
0.53%
Hold
39 450.00K $4.63M 0.51%
0.51%
Hold
40 450.00K $4.55M 0.50%
0.50%
New
41 450.00K $4.48M 0.49%
0.49%
New
42 450.00K $4.45M 0.49%
0.49%
New
43 408.15K $4.12M 0.45%
0.45%
New
44 379.14K $3.76M 0.41%
0.41%
New
45 392.00K $3.76M 0.41%
0.41%
New
46 350.00K $3.51M 0.39%
0.39%
New
47 5.02M $3.39M 0.37%
0.37%
Hold
48 2.53M $3.28M 0.36%
0.36%
Hold
49 548.99K $3.28M 0.36%
0.36%
Reduce
50 290.00K $2.88M 0.32%
0.32%
New

FAQ

What did MANGROVE PARTNERS IM, LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, MANGROVE PARTNERS IM, LLC reported 155 equity positions worth $909.39M in aggregate; its largest disclosed positions were RIO ($60.00M), LBRDK ($47.57M), LLYVK ($43.35M).

How large is MANGROVE PARTNERS IM, LLC's portfolio?

MANGROVE PARTNERS IM, LLC reported $909.39M of long equity holdings across 155 positions as of 2025-Q1. Top-10 holdings account for 43.9% of reported value.

What is MANGROVE PARTNERS IM, LLC's investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/mangrove-partners-im/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →